{"name":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","slug":"nanogen-pharmaceutical-biotechnology-joint-stock-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-12-31","label":"Neulastim Phase 3 readout (Primary Mediastinal Large B-Cell Lymphoma)","drug":"Neulastim","drugSlug":"neulastim","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-09-30","label":"Neulastim Phase 2 readout (Renal Pelvis and Ureter Urothelial Carcinoma)","drug":"Neulastim","drugSlug":"neulastim","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Faceptor","genericName":"Faceptor","slug":"faceptor","indication":"Other","status":"phase_3"},{"name":"Nanocovax","genericName":"Nanocovax","slug":"nanocovax","indication":"Other","status":"phase_3"},{"name":"Neulastim","genericName":"Neulastim","slug":"neulastim","indication":"Other","status":"discontinued"},{"name":"Stimus","genericName":"Stimus","slug":"stimus","indication":"Other","status":"phase_1"},{"name":"pegcyte","genericName":"pegcyte","slug":"pegcyte","indication":"Other","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Stimus (NNG-DEPO)","genericName":"Stimus (NNG-DEPO)","slug":"stimus-nng-depo","indication":"Attention deficit hyperactivity disorder (ADHD)","status":"phase_3"}]}],"pipeline":[{"name":"Faceptor","genericName":"Faceptor","slug":"faceptor","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nanocovax","genericName":"Nanocovax","slug":"nanocovax","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Neulastim","genericName":"Neulastim","slug":"neulastim","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Stimus","genericName":"Stimus","slug":"stimus","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Stimus (NNG-DEPO)","genericName":"Stimus (NNG-DEPO)","slug":"stimus-nng-depo","phase":"phase_3","mechanism":"Stimus (NNG-DEPO) is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.","indications":["Attention deficit hyperactivity disorder (ADHD)","Narcolepsy"],"catalyst":""},{"name":"pegcyte","genericName":"pegcyte","slug":"pegcyte","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOZ3h6VWlSd3ZOVXR5dGVLYVdRRUdJQWpKMlFpR25LZmZjVGMtT3JtV2Via2g1cDh2amxLaU1keGVhY3RCLW0tMGJqNlJVdTF0anFhQ2M4dTBEcHF3cURnbzNqSmo3WFhzQ0JEeVB6NnVsal95WkVSSXFkb2EzUk1MbElhMEV0Sk5LRUsxSkN5UUVVZXZpV2V2UHpxU05KSWtDVUlqVFpZbWlRbGNt?oc=5","date":"2025-05-13","type":"pipeline","source":"Laodong.vn","summary":"The passing of Mr. Ho Nhan and questions about the future of Nanogen - Laodong.vn","headline":"The passing of Mr. Ho Nhan and questions about the future of Nanogen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPZnk0a0E4UTZrZXBwMFVILWpNTjRoYXJYYzBqUnlaWXpWNUwwN0FKMHVQOVNrZU04TXRFeEpXdW1Jb1BHZ3lYczh2VElYZEpNRnhmZGcwTnhwa2lrZ0trM2MyekJHSTk5dlR4TXJnUEdVYTVKcjRYRS1rZnhJajE1bWNiZ2lXLWF6Mmd2NWdWN1VYOGczZW5BdWFkekFBX0xrU2JtZmVUOWZPOFQyaDFpbQ?oc=5","date":"2023-05-23","type":"pipeline","source":"vietnamnews.vn","summary":"Việt Nam has potential to become regional vaccine production centre - vietnamnews.vn","headline":"Việt Nam has potential to become regional vaccine production centre","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":4,"discontinued":1,"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}